Mink TherapeuticsINKT
13F holders, Q3 2025 (September 30)18holders −1
2new positions
3sold out
1famous investor
$14.00avg. 13F price*
At the end of Q3 2025, 18 institutions reported holding Mink Therapeutics Inc. (INKT) in their 13F filings, down 1 from Q2 2025. 2 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($467K), Longbow Finance SA ($233K) and Renaissance Technologies ($204K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Mink Therapeutics Inc.
- CUSIP
- 603693201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $217K |
| Exits | 3 | $10K |
All 13F filers, Q2 2025 → Q3 2025: 31,908 shares bought and 2,517 shares sold, net +29,391 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Vanguard Group Inc. | 0.00% | Add +40.5% | 33,351 | $467K |
| Longbow Finance SA | 0.02% | No change | 16,667 | $233K |
| Renaissance Technologies | 0.00% | New | 14,600 | $204K |
| Geode Capital Management, LLC | 0.00% | Add +11.4% | 12,806 | $179K |
| BlackRock, Inc. | 0.00% | Reduce -15.1% | 6,298 | $88K |
| UBS Group AG | 0.00% | Add +1888.7% | 5,648 | $79K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 926 | $13K |
| Bank of America Corp. | 0.00% | No change | 568 | $8K |
| Covestor Ltd | 0.00% | No change | 131 | $2K |
| Osaic Holdings, Inc. | 0.00% | Add +3.3% | 124 | $2K |
| Morgan Stanley | 0.00% | Add +422.7% | 115 | $2K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 19 | $266 |
| Game Plan Financial Advisors, LLC | 0.00% | No change | 16 | $224 |
| BNP Paribas Financial Markets | 0.00% | Reduce -38.5% | 16 | $224 |
| Clearstead Advisors, LLC | 0.00% | No change | 14 | $196 |
| JPMorgan Chase & Co. | 0.00% | Reduce -25.0% | 9 | $126 |
| Key Financial Inc | 0.00% | No change | 4 | $59 |
| Jones Financial Companies LLLP | 0.00% | No change | 1 | $14 |
"% of holder's portfolio" is INKT's weight in each manager's 13F, not the share of Mink Therapeutics Inc. the manager owns.